FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1539771040> ?p ?o ?g. }

• W1539771040 abstract "Diacylglycerol (DAG) is a ubiquitous lipid second messenger that transmits signals from cell membrane receptors to intracellular effector proteins containing a specialized DAG recognition motif, the C1 domain. The protein kinase C (PKC) family of serine/threonine kinases is the bestcharacterized member of DAG effectors, but there are also six other families of proteins with a DAGresponsive C1 domain: (1) the protein kinase D (PKD) family; (2) the myotonic dystrophy kinaserelated Cdc42-binding kinases (MRCKs); (3) the DAG kinases (DGKs); (4) the Munc13 proteins; (5) the chimaerins; and (6) the Ras guanyl-releasing proteins (RasGRPs). DAG-mediated signalling regulates many cellular functions such as cell proliferation, survival, differentiation, apoptosis and motility − processes that are often deregulated in cancer. As key mediators of these processes, several of the DAG effectors are regarded as promising targets for cancer drug development. Furthermore, PKC contributes to neuronal plasticity and inhibits many pathophysiological processes related to Alzheimer’s disease. Activation of PKC is therefore considered a potential future therapeutic strategy for the treatment of Alzheimer’s disease. The C1 domain thus represents a well-recognized drug target. However, the existing C1 domain ligands are extremely complex in their chemical structure and from the drug development point of view new C1 domain ligands with a feasible synthesis route are needed. The purpose of these studies was to characterize the structure-activity relationships (SAR) of a novel group of C1 domain ligands, derivatives of 5-(hydroxymethyl)isophthalic acid. These compounds have a simple chemical structure and they are easy to synthesize. Furthermore, these studies aimed to investigate the in vitro pharmacology of the isophthalate derivatives especially focusing on their effects on cell proliferation and morphology. The SAR studies revealed the structural elements indispensable for binding to the C1 domain of PKC: the hydroxymethyl group, both of the ester groups and sufficiently hydrophobic ester substituents. Importantly, the SAR model also held true with β2-chimaerin, another C1-domain containing DAG effector. The active isophthalates bound to PKC with low micromolar affinities, and a selected example of these, HMI-1a3, was also shown to bind to the C1 domains of PKD1 and MRCKα at similar concentrations. Several isophthalates had an antiproliferative effect in HeLa human cervical carcinoma cells. HMI-1a3 exhibited the most potent cytotoxic and antiproliferative effect of the derivatives tested. The isophthalates with no affinity to the C1 domain (e.g. NI-15e, the inactive derivative of HMI-1a3) had no effect on HeLa cell viability or proliferation, suggesting a C1 domain-mediated effect. HMI-1a3 also induced a morphological change characterized by cell elongation. It was accompanied with a marked reorganization of actin cytoskeleton: loss of focal adhesions and actin stress fibres. The elongation-inducing effect of HMI-1a3 was inhibited by an MRCK inhibitor, and thus seems to be at least partially mediated by MRCK. However, the mechanism of its antiproliferative effect remains unclear and may be mediated by several of the DAG effectors. In SH-SY5Y neuroblastoma cells, which are widely used as an in vitro model for neuronal differentiation, HMI-1b11 inhibited cell proliferation and supported neurite growth. HMI-1a3 induced SH-SY5Y cell differentiation as well, but unlike HMI-1b11 it also induced cell death. Again, derivatives with poor binding affinity to the C1 domain had no effect. The HMI-1b11-induced response was accompanied by PKC-dependent ERK1/2 phosphorylation and up-regulation of GAP43, which is known to mediate neuronal differentiation and to contribute to neurite outgrowth. In conclusion, these studies identify derivatives of 5-(hydroxymethyl)isophthalic acid as a promising novel group of C1 domain ligands. The antiproliferative and cytotoxic HMI-1a3 serves as a potential lead molecule for cancer-related drug discovery. HMI-1b11 on the other hand may be useful in drug development related to neurodegenerative diseases because of its non-toxic and differentiation-inducing properties in SH-SY5Y cells. More studies using cell-based and in vivo models are, however, needed to fully assess the potential of isophthalates in drug development." @default.
• W1539771040 created "2016-06-24" @default.
• W1539771040 creator A5017315850 @default.
• W1539771040 date "2013-11-22" @default.
• W1539771040 modified "2023-09-23" @default.
• W1539771040 title "The DAG-responsive C1 domain as a drug target: structure-activity and in vitro pharmacology of isophthalate derivatives" @default.
• W1539771040 cites W1483045044 @default.
• W1539771040 cites W1486602990 @default.
• W1539771040 cites W1487283699 @default.
• W1539771040 cites W1493948383 @default.
• W1539771040 cites W1508049002 @default.
• W1539771040 cites W1522765298 @default.
• W1539771040 cites W1525229364 @default.
• W1539771040 cites W1528279723 @default.
• W1539771040 cites W1539041881 @default.
• W1539771040 cites W1571754483 @default.
• W1539771040 cites W1590152235 @default.
• W1539771040 cites W1606913060 @default.
• W1539771040 cites W1786286483 @default.
• W1539771040 cites W187451175 @default.
• W1539771040 cites W1958742527 @default.
• W1539771040 cites W1963695842 @default.
• W1539771040 cites W1964586643 @default.
• W1539771040 cites W1966809742 @default.
• W1539771040 cites W1968504163 @default.
• W1539771040 cites W1968925987 @default.
• W1539771040 cites W1970279665 @default.
• W1539771040 cites W1970659123 @default.
• W1539771040 cites W1971147345 @default.
• W1539771040 cites W1972703706 @default.
• W1539771040 cites W1972895585 @default.
• W1539771040 cites W1973250430 @default.
• W1539771040 cites W1973556415 @default.
• W1539771040 cites W1974354892 @default.
• W1539771040 cites W1974638880 @default.
• W1539771040 cites W1977068073 @default.
• W1539771040 cites W1978318962 @default.
• W1539771040 cites W1979288156 @default.
• W1539771040 cites W1980242148 @default.
• W1539771040 cites W1980335514 @default.
• W1539771040 cites W1980814667 @default.
• W1539771040 cites W1981880855 @default.
• W1539771040 cites W1983872250 @default.
• W1539771040 cites W1984120526 @default.
• W1539771040 cites W1984313874 @default.
• W1539771040 cites W1984867277 @default.
• W1539771040 cites W1985174072 @default.
• W1539771040 cites W1987326119 @default.
• W1539771040 cites W1987445277 @default.
• W1539771040 cites W1987793183 @default.
• W1539771040 cites W1988223469 @default.
• W1539771040 cites W1989165494 @default.
• W1539771040 cites W1990127032 @default.
• W1539771040 cites W1991726315 @default.
• W1539771040 cites W1992993098 @default.
• W1539771040 cites W1993282564 @default.
• W1539771040 cites W1993557483 @default.
• W1539771040 cites W1995763262 @default.
• W1539771040 cites W1997034114 @default.
• W1539771040 cites W1997122431 @default.
• W1539771040 cites W1998349282 @default.
• W1539771040 cites W2000257688 @default.
• W1539771040 cites W2000271974 @default.
• W1539771040 cites W2001504986 @default.
• W1539771040 cites W2001692359 @default.
• W1539771040 cites W2004470352 @default.
• W1539771040 cites W2004585452 @default.
• W1539771040 cites W2004872546 @default.
• W1539771040 cites W2005470247 @default.
• W1539771040 cites W2008502778 @default.
• W1539771040 cites W2008575184 @default.
• W1539771040 cites W2009491510 @default.
• W1539771040 cites W2010065280 @default.
• W1539771040 cites W2010398967 @default.
• W1539771040 cites W2011039855 @default.
• W1539771040 cites W2011567844 @default.
• W1539771040 cites W2012179870 @default.
• W1539771040 cites W2013706577 @default.
• W1539771040 cites W2013815976 @default.
• W1539771040 cites W2016870453 @default.
• W1539771040 cites W2017289994 @default.
• W1539771040 cites W2017619080 @default.
• W1539771040 cites W2018658509 @default.
• W1539771040 cites W2019787829 @default.
• W1539771040 cites W2019868249 @default.
• W1539771040 cites W2021736150 @default.
• W1539771040 cites W2021911222 @default.
• W1539771040 cites W2022110987 @default.
• W1539771040 cites W2023662810 @default.
• W1539771040 cites W2024478414 @default.
• W1539771040 cites W2025921069 @default.
• W1539771040 cites W2027235796 @default.
• W1539771040 cites W2027259173 @default.
• W1539771040 cites W2027632911 @default.
• W1539771040 cites W2027731275 @default.
• W1539771040 cites W2027956332 @default.
• W1539771040 cites W2030515873 @default.
• W1539771040 cites W2031040858 @default.
• W1539771040 cites W2031432203 @default.
• W1539771040 cites W2031951506 @default.

• next